Dr. Agarwal’s Healthcare is set to launch its IPO on January 29, and it has already created a buzz in the grey market. Let’s take a closer look at the key points you need to know about this upcoming IPO from the latest GMP to the listing date.
Here’s everything you need to know of this issue Dr. Agarwal’s Healthcare IPO: Timeline
A mainboard issue, Dr. Agarwal’s Healthcare IPO will be opened for bidding from January 29 to January 31, with the anchor book opening a day earlier on January 28.
Dr. Agarwal’s Healthcare IPO: Size
With a total issue size of Rs 3,027 crore, Dr. Agarwal’s Healthcare IPO comprises a fresh issue of Rs 300 crore and an offer-for-sale (OFS) of 6.78 crore shares.
Dr. Agarwal’s Healthcare IPO: GMP
Ahead of the opening of the issue, Dr. Agarwal’s Healthcare IPO has created a significant buzz in the market. The shares of the company is trading at a premium of Rs 164, indicating a potential listing price of Rs 566 per share or 40.80% against the IPOs upper price band of Rs 402.
Dr. Agarwal’s Healthcare IPO: Key risk factors
As per the DRHP filing, some of the risk factors mentioned by the company in the disclosure include:
“Income from surgeries constitutes a significant majority of our revenue from operations (contributing to 64.20% of our revenue from operations in the Financial Year 2024) and any adverse effects on such income could adversely affect our business, financial condition, results of operations and cash flows.”
Also ReadDenta Water IPO Day 3 Live Updates: Check GMP, subscription, allotment status, and other details
“Our business depends on the strength of our brand equity and reputation. Failure to maintain and enhance our brand equity and reputation, including due to negative publicity, may adversely affect our business, reputation, financial condition, results of operations and prospects.”
Dr. Agarwal’s Healthcare IPO: Price band
The price band of the issue is set between the range of Rs 382 to Rs 402 per share.
Dr. Agarwal’s Healthcare IPO: Fund utilisation
The proceeds from the fresh issue will primarily be utilized to repay borrowings amounting to Rs 195 crore. Additionally, a portion of the funds will be allocated towards general corporate purposes and to support the company’s future growth plans.
» Read More
